4.99
price up icon3.31%   0.16
after-market アフターアワーズ: 4.88 -0.11 -2.20%
loading

Eledon Pharmaceuticals Inc (ELDN) 最新ニュース

pulisher
Oct 31, 2024

Biotechnology Value Fund L P's Strategic Acquisition in Eledon P - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

ELDN stock touches 52-week high at $4.13 amid robust gains - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

ELDN stock touches 52-week high at $4.13 amid robust gains By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

SEC Form 424B5 filed by Eledon Pharmaceuticals Inc. - Quantisnow

Oct 30, 2024
pulisher
Oct 30, 2024

Eledon drug helps transplants 'cure' type 1 diabetes - pharmaphorum

Oct 30, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals sets terms for $85 million stock offering By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon: Changing Scope Of Immunosuppressive Drug Space With Tegoprubart (ELDN) - Seeking Alpha

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Shares Hit 52-Week High After Positive Trial Data - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

Promising results for diabetes treatment with new drug By Investing.com - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals sets terms for $85 million stock offering - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine - The Manila Times

Oct 29, 2024
pulisher
Oct 29, 2024

Promising results for diabetes treatment with new drug - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Pricing of $85 Million - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Positive Initial Data from - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - StockTitan

Oct 29, 2024
pulisher
Oct 26, 2024

Algorae Pharmaceuticals Plans Major Securities Issuance - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

Midday Stock Roundup: The Ensign Group Beats Q3 Expectations - Orange County Business Journal

Oct 25, 2024
pulisher
Oct 23, 2024

ELDN stock soars to 52-week high, touches $3.35 amid surge - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

ELDN stock soars to 52-week high, touches $3.35 amid surge By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 04, 2024

Financial Analysis: Eledon Pharmaceuticals (NASDAQ:ELDN) & ABVC BioPharma (NASDAQ:ABVC) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

IgA nephropathy Clinical Trials 2024 (Updated): FDA Approvals, - openPR

Oct 03, 2024
pulisher
Oct 01, 2024

Eledon Pharmaceuticals completes $4 million equity sale - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Eledon Pharmaceuticals completes $4 million equity sale By Investing.com - Investing.com South Africa

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Invests $1.58 Million in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Acquires New Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - MarketBeat

Oct 01, 2024
pulisher
Sep 28, 2024

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Short Interest Update - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Midday Stock Roundup: STAAR Surgical CO. Shares Surge 22% - Orange County Business Journal

Sep 27, 2024
pulisher
Sep 20, 2024

Eledon Pharmaceuticals initiates $75 million stock sale agreement By Investing.com - Investing.com Australia

Sep 20, 2024
pulisher
Sep 20, 2024

Eledon Pharmaceuticals initiates $75 million stock sale agreement - Investing.com

Sep 20, 2024
pulisher
Sep 11, 2024

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference - GlobeNewswire

Sep 11, 2024
pulisher
Sep 04, 2024

ELDNEledon Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

Eledon Announces Completion of Enrollment in Phase 2 BESTOW - GlobeNewswire

Sep 04, 2024
pulisher
Sep 04, 2024

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients - StockTitan

Sep 04, 2024
pulisher
Sep 02, 2024

Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Declines By 6.8% - MarketBeat

Sep 02, 2024
pulisher
Aug 23, 2024

Analysts Issue Forecasts for Eledon Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:ELDN) - MarketBeat

Aug 23, 2024
pulisher
Aug 23, 2024

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Expected to Earn Q3 2024 Earnings of ($0.20) Per Share - Defense World

Aug 23, 2024
pulisher
Aug 20, 2024

Vanguard Group Inc. Has $2 Million Stock Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - MarketBeat

Aug 20, 2024
pulisher
Aug 19, 2024

S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

TSX Consumer Discretionary Capped Index (TTCD) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

2 'Strong Buy'-Rated Stocks That Wall Street Believes Can Soar Over 360% - TradingView

Aug 19, 2024
pulisher
Aug 19, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

Eledon Pharmaceuticals Inc (ELDN-Q) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 14, 2024

Eledon Expects to Restate Results, Delays Quarterly Report - MarketWatch

Aug 14, 2024
pulisher
Aug 14, 2024

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results - GlobeNewswire

Aug 14, 2024
pulisher
Aug 02, 2024

Eledon Pharmaceuticals (NASDAQ:ELDN) Stock Price Down 1.7% - MarketBeat

Aug 02, 2024
pulisher
Aug 02, 2024

Eledon Pharmaceuticals (NASDAQ:ELDN) Shares Down 1.7% - Defense World

Aug 02, 2024
pulisher
Jul 29, 2024

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial - GlobeNewswire

Jul 29, 2024
pulisher
Jul 29, 2024

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection - Yahoo Finance

Jul 29, 2024
pulisher
Jul 26, 2024

Midday Stock Roundup: BJ’s Drops on Revenue Miss - Orange County Business Journal

Jul 26, 2024
pulisher
Jul 24, 2024

4 High-Risk, High-Reward Small-Cap Stocks to Play the Rotation - Investing.com

Jul 24, 2024
pulisher
Jul 24, 2024

Amyotrophic Lateral Sclerosis Treatment Market size is set to grow by USD 663.7 million from 2024-2028, Increase in incidence and prevalence of amyotrophic lateral sclerosis to boost the market growth, Technavio - The Malaysian Reserve

Jul 24, 2024
pulisher
Jul 22, 2024

2 Penny Stocks Wall Street Expects to Soar Over 400% - TradingView

Jul 22, 2024
pulisher
Jul 13, 2024

Eledon Pharmaceuticals appoints Crowe as new auditor - Investing.com

Jul 13, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):